Why the study?
Hypertension in adolescents and young adults is associated with increased cardiovascular mortality, yet these patients have lower overall cardiovascular risk, are treated less often, and treatment efficacy takes longer to manifest.
Highlights the clinical necessity of diagnosing and treating arterial hypertension in adolescents and young adults to mitigate long-term cardiovascular mortality risk.
Highlights need for hypertension screening in young adults; leaves open optimal thresholds and long-term outcomes.
Hypertenze je jednĂm z nejvĂ˝znamnÄjĹĄĂch rizikovĂ˝ch faktorĹŻ kardiovaskulĂĄrnĂ morbidity a mortality v bÄĹžnĂŠ populaci stĹednĂho a starĹĄĂho vÄku, kterĂĄ se vyskytuje u 30-40 % populace. U adolescentĹŻ a mladĂ˝ch lidĂ je vĂ˝skyt hypertenze vĂ˝raznÄ niŞťà (2-10 %), pacienti majĂ menĹĄĂ celkovĂŠ kardiovaskulĂĄrnĂ riziko, mĂŠnÄ jsou lĂŠÄeni a trvĂĄ delĹĄĂ dobu, neĹž by se efektivita lĂŠÄby projevila. PĹesto je nutnĂŠ hypertenzi i u mladĂ˝ch lidĂ diagnostikovat a lĂŠÄit, neboĹĽ i ta je spojenĂĄ se zvýťenou kardiovaskulĂĄrnĂ ĂşmrtnostĂ.
No takes yet. Share an insight, caveat, or question.
Tomáš Seeman (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: